<div class="bodyItems-wrapper"> By Jessica DiNapoli and Waylon Cunningham NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say. More Americans are expected to try the ​drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves. The U.S. ‌Food and Drug Administration approved Novo Nordisk's (<a data-i13n="cpos:1;pos:1" href="https://finance.yahoo.com/quote/NVO/" data-ylk="slk:NVO;cpos:1;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link ">NVO</a>) Wegovy GLP-1 pill on Monday, sending shares of food companies down on Tuesday. Eli Lilly's (<a data-i13n="cpos:2;pos:1" href="https://finance.yahoo.com/quote/LLY/" data-ylk="slk:LLY;cpos:2;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link ">LLY</a>) rival medication is expected to gain approval from regulators next year. Food ‌companies including Conagra Brands and Nestle are already dealing with shifts in consumer tastes toward higher protein and smaller portions due to the popularity of weight-loss injections, and analysts believe widespread GLP-1 adoption could mean long-term changes in demand. To cope, businesses are promoting products with more protein, tweaking labeling to say they are GLP-1 friendly and working with large retailers to better market products. "We are seeing people cut (back) specifically on salty snacks, liquor, soda, drinks, and bakery snacks, and more focused on protein and fiber, so we ⁠expect food companies and also restaurants to cater to ‌this audience that is growing," said JP Frossard, consumer foods analyst at Rabobank. "We'll see more access to those drugs and a higher addressable market for products that have in mind the needs of the GLP-1 user," he said. Andrew Rocco, stock strategist at ‍Zacks Investment Research, called Novo's approval "groundbreaking" because the pill would be cheaper than the injectable version of Wegovy and deliver the same weight-loss metrics. "High protein, smaller portions, and functional food innovation will be necessary," he said. <h2 class="header-scroll yf-1u6g9f6" id="food-companies-are-taking-note">FOOD COMPANIES ARE TAKING NOTE</h2> Some 40% of American adults are obese, U.S. government data shows, and around 12% of adults say they currently take GLP-1 drugs, ​according to a poll published last month by health policy research organization KFF. Households using GLP-1 medications cut spending at grocery stores by 5.3% and fast-food restaurants ‌by about 8% on average, according to a Cornell Research study published last week that used purchase data collected by Numerator from about 150,000 households. Those reductions largely faded when households stopped using the medication. "The decreases we saw will likely show up in a much broader slice of the population" because of weight-loss pills, said Sylvia Hristakeva, one of the study's co-authors. She said the cheaper price and ease of use of pills will also make it likely that people use the medication for longer. </div>

NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say. More Americans are expected to try the ​drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.

Weight-loss pill approval set to accelerate food industry product overhauls

Preschool programs are intended to furnish small kids with different abilities important for their progress into standard school.


Understanding Preschool Projects: Cultivating Abilities and Advancement


PC games have turned into a significant piece of present day diversion, offering vivid encounters that reach from extraordinary activity to profound


Vote In favor of Your Favored Comupter Game


The TV personality talks about her new chapter, the recent death of her mother and the secret to 20 years of marriage with husband John Cusimano.

Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.

As innovation keeps on propelling, the manner in which we approach rest is advancing with it. Brilliant beds are at the front


The Fate of Rest: Patterns in Shrewd Beds


Houseplants and office plants are something other than beautifying components; they bring life, variety, and a dash of nature inside.


Simple Consideration Plants for Home and Office: An Aide


Shuffling a web-based degree with life's different responsibilities demands fastidious using time effectively. However, with the right methodologies, it's feasible to


Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree


Pies are a dearest dessert delighted in by a lot of people for their delectable fillings and flaky outsides. Whether sweet or appetizing, pies


Vote in favor of Your Number one kind of pie


Electric vehicles (EVs) have flooded in notoriety, offering harmless to the ecosystem options in contrast to customary fuel controlled vehicles. In 2023, a few EV models


The Manual for Electric Vehicles that will be hot dealers in 2023


Drone strikes on a town in South Kordofan on Thursday are said to have killed at least 50 people.

Deadly attack on kindergarten reported in Sudan

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.

Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds

Boeing and NASA have agreed to keep astronauts off the company’s next Starliner flight and instead perform a trial run with cargo to prove its safety.  Monday’s announcement comes eight months after the first and only Starliner crew returned to Earth aboard SpaceX after a prolonged mission.  Although NASA test pilots Butch Wilmore and Suni Williams managed to dock Starliner to the International Space Station in 2024, the capsule had so many problems that NASA ordered it to come back empty, leavi

Boeing's troubled capsule won't carry astronauts on next space station flight

Hypnosis can help day traders because it's about accessing a person's unconscious mind, which can change automatic behaviors, one hypnotherapist said.

I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works.

A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the lining of her lungs.  Jurors determined that plaintiff Anna Jean Houghton Carley, 37, should be compensated by Johnson & Johnson after using its baby powder throughout her childhood and later developing mesothelioma, an aggressive cancer caused primarily by exposure to the carcinogen asbestos.  Johnson

Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder

Emotional well-being matters profoundly, and my fight with tension has been a huge piece of my life. On this page's
